Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [ ¹⁸ F]flortaucipir imaging

Abstract

Background: The US Food and Drug Administration and the European Medicines Agency recently approved a visual read method for the Tau‐PET radiotracer [ ¹⁸ F]flortaucipir to support the clinical diagnosis of Alzheimer's disease.

The paper